Skip to content

Other

Terbutaline sulfate [USAN:JAN]

CAS 23031-32-5
18

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

A beta-2 adrenergic bronchodilator drug used to treat asthma and COPD. Labelled with H361 (suspected reproductive toxicity) and is not permitted in cosmetic formulations under EU cosmetics law.

Terbutaline sulfate is a synthetic catecholamine that acts primarily on beta-2 receptors to relax bronchial smooth muscle. It carries the GHS signal word 'Warning' and hazard H361 (suspected reproductive toxicity). EU cosmetics regulation does not permit bronchodilator drugs as cosmetic ingredients; they are regulated as medicinal products.

Known concerns

  • H361 — suspected reproductive toxicity
  • EU regulated as medicinal substance, not cosmetics ingredient
  • Cardiovascular effects (tachycardia, palpitations)
  • Neurological effects possible

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Related others

Check your shelf

Find Terbutaline sulfate [USAN:JAN] in your products.

Scan any cosmetic product with LuxSense to see if it contains Terbutaline sulfate [USAN:JAN] and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.